Phenolics from Garcinia mangostana alleviate exaggerated vasoconstriction in metabolic syndrome through direct vasodilatation and nitric oxide generation.
ガルシニア・マンゴスターナ由来フェノール化合物は、直接血管拡張と一酸化窒素産生を介してメタボリックシンドロームにおける過剰な血管収縮を軽減する (機械翻訳の邦題)
記録の確認項目
- 研究デザイン
- その他の原著論文
- 対象
- 動物
- 出版年
- 2016
- 出典
- doi.org
- 抄録の表示
- 表示あり
- 出版状態
- 有効な記録
- 状態確認日
- 2026/08/17
- 収集日
- 2026/08/03
- 鮮度
- 確認期限内
- 確認段階
- 自動処理
- 記録状態
- 公開
日本語要約(機械生成)
メタボリックシンドローム(MetS)における過剰な血管収縮に対するガルシニア・マンゴスターナ果皮メタノール抽出物(GMT)の保護効果を、MetS動物から単離した大動脈を用いて検討した。バイオアッセイガイド分画により、6種のフェノール化合物を単離し、そのうち化合物2(アロマデンドリン-8-C-β-D-グルコピラノシド)、4(ロダンテノン)、5(エピカテキン)がMetS大動脈の過剰な血管収縮を有意に軽減し、フェニレフリン収縮血管に対して有意な血管拡張を示した。この血管拡張は一酸化窒素(NO)合成酵素阻害薬とグアニル酸シクラーゼ阻害薬で完全に阻害されたが、カリウムチャネル遮断薬やシクロオキシゲナーゼ阻害薬の影響は受けなかった。また、これらの化合物は大動脈からのNO産生をアセチルコリンと同等レベルに刺激し、化合物4と5は活性酸素種の産生を抑制した。以上より、これらのフェノール化合物は血管拡張とNO産生を介してMetSの過剰な血管収縮を改善することが示された。
この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。
抄録
Background: Exaggerated vasoconstriction plays a very important role in the hypertension, a major component of metabolic syndrome (MetS). In the current work, the potential protective effect of methanol extract of fruit hulls of Garcinia mangostana L. on the exaggerated vasoconstriction in MetS has been investigated. In addition, the bioactive fraction and compounds as well as the possible mechanism of action have been illustrated.Methods: The effect of methanol extract of G. mangostana (GMT) fruit hulls on the vascular reactivity of aorta isolated from animals with MetS was investigated through bioassay-guided fractionation procedures. GMT was partitioned with chloroform (I) and the remaining mother liquor was fractionated on a Diaion HP-20 with H2O, 50 and 100 % methanol to give fractions II, III, and IV, respectively. The effect of total extract (GMT), bioactive fraction and the bioactive compounds on the vasoconstriction were examined in aortae isolated from animals with MetS by incubation for 30 min before exposing aortae to cumulative concentrations of phenylephrine (PE). The direct relaxant effect was also examined by adding cumulative concentrations of the bioactive fraction and its bioactive compounds to PE precontracted vessels. In addition, aortic nitric oxide (NO) and reactive oxygen species (ROS) production was investigated.Results: Bioassay-guided fractionation of GMT revealed isolation of garcimangosone D (1), aromadendrin-8-C-β-D-glucopyranoside (2), 2,4,3'-trihydroxy benzophenone-6-O-β-D-glucopyranoside (3), maclurin-6-O-β-D-glucopyranoside (rhodanthenone) (4), epicatechin (5), and 2,3',4,5',6-pentahydroxy benzophenone (6). Only compounds 2, 4, and 5 significantly alleviated the exaggerated vasoconstriction of MetS aortae and in the same time showed significant vasodilation of PE pre-contracted aortae. To further illustrate the mechanism of action, the observed vasodilation was completely blocked by the nitric oxide (NO) synthase inhibitor, Nω-nitro-L-arginine methyl ester hydrochloride and inhibited by guanylate cyclase inhibitor, methylene blue. However, vasodilation was not affected by the potassium channel blocker, tetraethylammonium or the cyclooxygenase inhibitor, indomethacin. In addition, compounds 2, 4, and 5 stimulated NO generation from isolated aortae to levels comparable with acetylcholine. Furthermore, 4 and 5 inhibited reactive oxygen species generation in MetS aortae.Conclusion: The phenolic compounds 2, 4, and 5 ameliorated the exaggerated vasoconstriction in MetS aortae through vasodilatation-NO generation mechanism.
MeSH
DOI 10.1186/s12906-016-1340-5
PMID 27618982
原文・出典を見る →